Belda-Ferre, P., Alcaraz, L. D., Cabrera-Rubio, R., Romero, H., Simón-Soro, A., Pignatelli, M., & Mira, A. (2012). The oral metagenome in health and disease. Isme j, 6(1), 46-56.
Bonhomme, D., Santecchia, I., Vernel-Pauillac, F., Caroff, M., Germon, P., Murray, G., . . . Werts, C. (2020). Leptospiral LPS escapes mouse TLR4 internalization and TRIF‑associated antimicrobial responses through O antigen and associated lipoproteins. PLoS Pathog, 16(8), e1008639.
Carson, H. J., Rezmer, S., & Belli, J. (1997). Haemophilus segnis cholecystitis: a case report and literature review. J Infect, 35(1), 85-86.
Cross, B. W., & Ruhl, S. (2018). Glycan recognition at the saliva - oral microbiome interface. Cell Immunol, 333, 19-33.
Dewhirst, F. E., Chen, T., Izard, J., Paster, B. J., Tanner, A. C., Yu, W. H., . . . Wade, W. G. (2010). The human oral microbiome. J Bacteriol, 192(19), 5002-5017.
Escapa, I. F., Chen, T., Huang, Y., Gajare, P., Dewhirst, F. E., & Lemon, K. P. (2018). New Insights into Human Nostril Microbiome from the Expanded Human Oral Microbiome Database (eHOMD): a Resource for the Microbiome of the Human Aerodigestive Tract. mSystems, 3(6), e00187-00118.
Fan, X., Alekseyenko, A. V., Wu, J., Peters, B. A., Jacobs, E. J., Gapstur, S. M., . . . Ahn, J. (2018). Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut, 67(1), 120-127.
Fan, Y., & Pedersen, O. (2021). Gut microbiota in human metabolic health and disease. Nat Rev Microbiol, 19(1), 55-71.
Farrell, J. J., Zhang, L., Zhou, H., Chia, D., Elashoff, D., Akin, D., . . . Wong, D. T. (2012). Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut, 61(4), 582-588.
Flemer, B., Warren, R. D., Barrett, M. P., Cisek, K., Das, A., Jeffery, I. B., . . . O'Toole, P. W. (2018). The oral microbiota in colorectal cancer is distinctive and predictive. Gut, 67(8), 1454-1463.
Fomsgaard, A., Freudenberg, M. A., & Galanos, C. (1990). Modification of the silver staining technique to detect lipopolysaccharide in polyacrylamide gels. J Clin Microbiol, 28(12), 2627-2631.
Frenkel, E. S., & Ribbeck, K. (2015). Salivary mucins in host defense and disease prevention. J Oral Microbiol, 7, 29759.
Hölzer, S. U., Schlumberger, M. C., Jäckel, D., & Hensel, M. (2009). Effect of the O-antigen length of lipopolysaccharide on the functions of Type III secretion systems in Salmonella enterica. Infect Immun, 77(12), 5458-5470.
Irfan, M., Delgado, R. Z. R., & Frias-Lopez, J. (2020). The Oral Microbiome and Cancer. Front Immunol, 11, 591088.
Kalynych, S., Morona, R., & Cygler, M. (2014). Progress in understanding the assembly process of bacterial O-antigen. FEMS Microbiol Rev, 38(5), 1048-1065.
Kawakubo, M., Ito, Y., Okimura, Y., Kobayashi, M., Sakura, K., Kasama, S., . . . Nakayama, J. (2004). Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science, 305(5686), 1003-1006.
Kilian, M. (1976). A taxonomic study of the genus Haemophilus, with the proposal of a new species. J Gen Microbiol, 93(1), 9-62.
Lamont, R. A.-O., Koo, H., & Hajishengallis, G. A.-O. (2018). The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol, 16(12), 745-759.
Lee, K. A., Luong, M. K., Shaw, H., Nathan, P., Bataille, V., & Spector, T. D. (2021). The gut microbiome: what the oncologist ought to know. Br J Cancer.
Ling, Z., Liu, X., Cheng, Y., Jiang, X., Jiang, H., Wang, Y., & Li, L. (2015). Decreased Diversity of the Oral Microbiota of Patients with Hepatitis B Virus-Induced Chronic Liver Disease: A Pilot Project. Sci Rep, 5, 17098.
Liu, X., Yu, H., Qiao, Y., Yang, J., Shu, J., Zhang, J., . . . Li, Z. (2018). Salivary Glycopatterns as Potential Biomarkers for Screening of Early-Stage Breast Cancer. EBioMedicine, 70-79.
Long, J., Cai, Q., Steinwandel, M., Hargreaves, M. K., Bordenstein, S. R., Blot, W. J., . . . Shu, X. O. (2017). Association of oral microbiome with type 2 diabetes risk. J Periodontal Res, 52(3), 636-643.
Lynge Pedersen, A. M., & Belstrøm, D. (2019). The role of natural salivary defences in maintaining a healthy oral microbiota. J Dent, 80 Suppl 1, S3-s12.
Meurman, J. H. (2010). Oral microbiota and cancer. J Oral Microbiol, 2.
Michaud, D. S., Fu, Z., Shi, J., & Chung, M. (2017). Periodontal Disease, Tooth Loss, and Cancer Risk. Epidemiol Rev, 39(1), 49-58.
Michaud, D. S., Kelsey, K. T., Papathanasiou, E., Genco, C. A., & Giovannucci, E. (2016). Periodontal disease and risk of all cancers among male never smokers: an updated analysis of the Health Professionals Follow-up Study. Ann Oncol, 27(5), 941-947.
Ndegwa, N., Ploner, A., Liu, Z., Roosaar, A., Axéll, T., & Ye, W. (2018). Association between poor oral health and gastric cancer: A prospective cohort study. Int J Cancer, 143(9), 2281-2288.
Nørskov-Lauritsen, N., & Kilian, M. (2006). Reclassification of Actinobacillus actinomycetemcomitans, Haemophilus aphrophilus, Haemophilus paraphrophilus and Haemophilus segnis as Aggregatibacter actinomycetemcomitans gen. nov., comb. nov., Aggregatibacter aphrophilus comb. nov. and Aggregatibacter segnis comb. nov., and emended description of Aggregatibacter aphrophilus to include V factor-dependent and V factor-independent isolates. Int J Syst Evol Microbiol, 56(Pt 9), 2135-2146.
Peters, B. A., Wu, J., Pei, Z., Yang, L., Purdue, M. P., Freedman, N. D., . . . Ahn, J. (2017). Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers. Cancer Res, 77(23), 6777-6787.
Revest, M., Egmann, G., Cattoir, V., & Tattevin, P. (2016). HACEK endocarditis: state-of-the-art. Expert Rev Anti Infect Ther, 14(5), 523-530.
Shang, F. M., & Liu, H. L. (2018). Fusobacterium nucleatum and colorectal cancer: A review. World J Gastrointest Oncol, 10(3), 71-81.
Shu, J., Ma, J., Ren, X., Wang, J., Wang, Y., Zhang, K., . . . Li, Z. (2021). The Abnormal Glycopatterns of Salivary Glycoproteins in Esophageal Squamous Cell Carcinoma Patients Front Chem, 9, 637730.
Shu, J., Yu, H., Du, H., Zhang, J., Zhang, K., Li, X., . . . Li, Z. (2018). Identification of N- and O-linked glycans recognized by AAL in saliva of patients with atrophic gastritis and gastric cancer. Cancer Biomarkers, 22(4), 669-681.
Shu, J., Yu, H., Li, X., Zhang, D., & Liu, X. (2017). Salivary glycopatterns as potential biomarkers for diagnosis of gastric cancer. oncotarget, 8(22), 35718-35727.
Sun, J., Tang, Q., Yu, S., Xie, M., Xie, Y., Chen, G., & Chen, L. (2020). Role of the oral microbiota in cancer evolution and progression. Cancer Med, 9(17), 6306-6321.
Sun, J., Zhou, M., Salazar, C. R., Hays, R., Bedi, S., Chen, Y., & Li, Y. (2017). Chronic Periodontal Disease, Periodontal Pathogen Colonization, and Increased Risk of Precancerous Gastric Lesions. J Periodontol, 88(11), 1124-1134.
Welch, W. D., Southern, P. M., Jr., & Schneider, N. R. (1986). Five cases of Haemophilus segnis appendicitis. J Clin Microbiol, 24(5), 851-852.
Whitmore, S. E., & Lamont, R. J. (2014). Oral bacteria and cancer. PLoS Pathog, 10(3), e1003933.
Wu, J., Xu, S., Xiang, C., Cao, Q., Li, Q., Huang, J., . . . Zhan, Z. (2018). Tongue Coating Microbiota Community and Risk Effect on Gastric Cancer. J Cancer, 9(21), 4039-4048.
Xu, D., Pavlidis, P., Taskent, R. O., Alachiotis, N., Flanagan, C., DeGiorgio, M., . . . Gokcumen, O. (2017). Archaic Hominin Introgression in Africa Contributes to Functional Salivary MUC7 Genetic Variation. Mol Biol Evol, 34(10), 2704-2715.
Yang, J., Zhou, Y., Zhang, L., Shah, N., Jin, C., Palmer, R. J., Jr., & Cisar, J. O. (2016). Cell Surface Glycoside Hydrolases of Streptococcus gordonii Promote Growth in Saliva. Appl Environ Microbiol, 82(17), 5278-5286.
Zhang, J., Zhong, Y., Zhang, P., Du, H., Shu, J., Liu, X., . . . Li, Z. (2019). Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Glycobiology, 29(3), 242-259.